ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PYC Physiomics Plc

1.55
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.55 1.50 1.60 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.43 2.1M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.55p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £2.10 million. Physiomics has a price to earnings ratio (PE ratio) of -4.43.

Physiomics Share Discussion Threads

Showing 20401 to 20419 of 30125 messages
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older
DateSubjectAuthorDiscuss
23/2/2018
10:08
Pwhite please don't bring anymore bad news to this losing con story. Just lie to me and tell me that pyc will spike by 500% or just buy me some rose tinted glasses.
spacedust
23/2/2018
08:42
Mini tumours grown outside the human body for drug treatment is all over the national news today. It was on the radio and TV. The drugs have 88% and 100% accuracy. Who needs computational models when you can test drugs on the real thing outside the human body. Do you see how fast this science moves.
pwhite73
23/2/2018
07:35
Stig
Agree 100%

And all this withouth factoring in the Merck-like 0.5 million contracts in the next months.

10p, then 50p then 1quid then our early retirement

the patient investor
23/2/2018
00:30
The Interims being historic weren't all that important from a numbers point of view as we basically knew what was coming anyway.

One very positive thing nobody has mentioned as far as I can see is the cashflow situation.

Despite a Headline Operating Loss of £220k the actual cash outflow was only c. £40k on a Revenue base of only £170k

i.e. with a Revenue base in the second half of £200k (Merck) + £30k + £70k = £300k we should be looking at a cashflow positive 2nd half?

even more so if we get more 'Substantial Non-Dilutive' funding from Government on the Cancer DSS tool

the stigologist
22/2/2018
18:46
True no Lamborghini*
spacedust
22/2/2018
18:45
True Lamborghini but will look to take dividends and go for the smooth rise towards 200p.
spacedust
22/2/2018
17:22
Ok I'll qualify what I said. To say NO PIs are selling would be patently untrue, of course aome PIs are selling but far more are interested in buying at this level than selling. But the excess demand is being met by MM drip feeding unplaced placing shares into the markets. Just look at that huge 400k buy at 11:25 where do think the shares are coming from?

Good luck with Centrica but you'll never be able to buy a Lamborghini invested in that company.

pwhite73
22/2/2018
17:16
I have been pwhite. I'm sticking with main markets. Bought in centrica today after the resultsthis morning.
spacedust
22/2/2018
16:10
Yep
We could break 10p easily on a good RNS in a matter of HOURS

LARGELY OVERSOLD

the patient investor
22/2/2018
14:54
Only a matter of time before #PYC starts to get its share of this market now its tech is validated and starting the rapid adoption curve by Big Pharma
the stigologist
22/2/2018
14:53
Just a $3bn cancer treatment deal
the stigologist
22/2/2018
11:41
Cheers wossupsa. Nice to see the recovery at IMM
volsung
21/2/2018
21:42
All of it volsung (good call on IMM at 109p btw)?
wossupsa
21/2/2018
17:36
myamay16 re: 1816, don't you know an auto-generated article when you see one? No human has written that it's a template with some figures slotted in. Then at the bottom they want you to pay to read other auto-generated cr$p.
on target
21/2/2018
17:29
Maybe, Maybe one day will be doing this with PYC.

Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline
Proposed Acquisition of Viralytics Would Add Investigational Oncolytic Immunotherapy, CAVATAK ® , Supporting Merck’s Strategy to Broaden Its Pipeline with the Best Scientific Assets

Wednesday, February 21, 2018 4:00 am EST

KENILWORTH, N.J. & SYDNEY--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Viralytics Limited (ASX: VLA, OTC: VRACY) today announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded company focused on oncolytic immunotherapy treatments for a range of cancers by way of a scheme of arrangement (Scheme) for AUD 1.75 cash per Viralytics share. The proposed acquisition values the total issued shares in Viralytics at approximately AUD 502 million (USD 394 million). The cash consideration of AUD 1.75 per share represents a premium of 160% to the one month volume weighted average price (VWAP) of Viralytics share

hxxp://www.mrknewsroom.com/news-release/oncology-newsroom/merck-and-viralytics-announce-acquisition-agreement-expanding-mercks-

myamay16
21/2/2018
17:25
3rd article by Simply Walls st in as many months about PYC ( they showing some interest here ).

Who Owns Physiomics Plc (LON:PYC)?
Micheal Lombardo February 21, 2018
In this article, I will take a quick look at Physiomics Plc’s (AIM:PYC) recent ownership structure – an unconventional investing subject, but an important one. When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. Differences in ownership structure of companies can have a profound effect on how management’s incentives are aligned with shareholder returns, and whether they adhere to corporate governance best practices. Although this is an important factor for long-term investors, many investors can also be impacted by institutional presence and their high-volume trading. Therefore, it is beneficial for us to examine PYC’s ownership structure in more detail.

hxxps://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-pyc/physiomics-shares/news/who-owns-physiomics-plc-lonpyc/

myamay16
21/2/2018
16:19
Balls shrinking time.
spacedust
21/2/2018
15:28
Thats what's happened to me with PYC since 2009. And silly me bought in again when I saw JC holdings.

I'll stick to BT TLW and national grid. Anything comes of this I'll see it as a bonus

spacedust
21/2/2018
15:17
spacedust Yes shorting AIM stocks is the way to go but as a PI they won't let you do it because its a sure fire way to make money. If they ever let you short a stock that's because they know news or heavy buying is on the way to burn you. You can only make money from a surprise where PIs rush in before MM have enough stock to meet demand. This is what happened to PYC in November 2017.Takeovers, oil and gold finds are the types of shocks to the system where MM cannot react quickly enough. But if you just sit on your hands waiting for news they'll casserole you.
pwhite73
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older

Your Recent History

Delayed Upgrade Clock